COVID-19 Vaccine: Covaxin Found Safe, With No Major Adverse Events In 2 Phases Of Trials : Bharat Biotech
The Drugs Controller General of India (DCGI) recently approved Bharat Biotech to conduct phase 3 clinical trials India’s first indigenous coronavirus vaccine, Covaxin. The Hyderabad-based company had submitted the interim…
Share